Comparitive Effectiveness of PME Versus Transthoracic Echocardiogram (TTE)
Launched by SCRIPPS TRANSLATIONAL SCIENCE INSTITUTE · May 16, 2014
Trial Information
Current as of August 14, 2025
Completed
Keywords
ClinConnect Summary
A new hand held pocket echo device (GE Vscan) has now become available to clinicians, with limited data available comparing the effectiveness of this device as a screening tool when compared to TTE.
We are evaluating the effectiveness of this HHE device in detecting cardiac pathology in a both an inpatient and outpatient clinical setting as compared to a comprehensive TTE evaluation.
This study compares the images from the two modalities with regards to multiple parameters typically evaluated by traditional TTE. This would include the following:
1. Ejection fraction: estimates how well t...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. All subjects with an order for a routine transthoracic echocardiogram based on clinical indications.
- • 2. Vscan images will be obtained to evaluate multiple parameters (noted on research summary).
- • 3. Immediately after Vscan imaging, a complete transthoracic echocardiogram will be performed.
- • 4. Images will be compared between the Vscan device and the traditional transthoracic echocardiogram.
- Exclusion Criteria:
- • 1. Subjects who had a limited transthoracic echocardiography (i.e limited views)
- • 2. Vscan imaging not attempted for a certain parameter
About Scripps Translational Science Institute
The Scripps Translational Science Institute (STSI) is a leading research organization dedicated to advancing translational medicine and enhancing the integration of scientific discoveries into clinical practice. Affiliated with the renowned Scripps Research Institute, STSI focuses on innovative approaches to accelerate the development of new therapies and diagnostics, bridging the gap between laboratory research and patient care. By leveraging cutting-edge technologies and fostering collaborative partnerships, STSI aims to improve health outcomes and address unmet medical needs through rigorous clinical trials and research initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
La Jolla, California, United States
Patients applied
Trial Officials
Eric Topol, MD
Principal Investigator
Scripps Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials